[Federal Register Volume 75, Number 161 (Friday, August 20, 2010)]
[Notices]
[Pages 51466-51467]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-20675]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of the Director, National Institutes of Health; Notice of
Meeting
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of a meeting of the
Scientific Management Review Board.
The NIH Reform Act of 2006 (Pub. L. 109-482) provides
organizational authorities to HHS and NIH officials to: (1) Establish
or abolish national research institutes; (2) reorganize the offices
within the Office of the Director, NIH including adding, removing, or
transferring the functions of such offices
[[Page 51467]]
or establishing or terminating such offices; and (3) reorganize,
divisions, centers, or other administrative units within an NIH
national research institute or national center including adding,
removing, or transferring the functions of such units, or establishing
or terminating such units. The purpose of the Scientific Management
Review Board (also referred to as SMRB or Board) is to advise
appropriate HHS and NIH officials on the use of these organizational
authorities and identify the reasons underlying the recommendations.
The meeting will be open to the public, with attendance limited to
space available. Individuals who plan to attend and need special
assistance, such as sign language interpretation or other reasonable
accommodations, should notify the Contact Person listed below in
advance of the meeting.
Name of Committee: Scientific Management Review Board.
Date: September 14-15, 2010.
Time: September 14, 2010, 8:30 a.m. to 5:30 p.m.
Agenda: The focus of this meeting will be on the deliberations
of the Translational Medicine and Therapeutics working group and its
respective stakeholder consultation. Presentation and discussion
will include, but is not limited to, representatives from academia,
government, industry, venture capital firms, and patient advocacy
groups. Additional presentation and discussion will include
recommendations from the Substance Use, Abuse and Addiction working
group and the Intramural Research Program working group. Time will
be allotted both days for presentation and discussion of each
Working Group's recommendations. Any supporting documentation for
this meeting, including the agenda, will be available at http://smrb.od.nih.gov. Sign up for public comment will begin at
approximately 7:30 a.m. on both September 14 and 15 and will be
restricted to one sign in per person. In the event that time does
not allow for all those interested to present oral comments, anyone
may file written comments using the contact person's address below.
Place: National Institutes of Health, Building 31, 6th Floor,
Conference Room 6, 31 Center Drive, Bethesda, MD 20892.
Time: September 15, 2010, 8 a.m. to 5 p.m.
Agenda: Continuation of September 14th meeting.
Place: National Institutes of Health, Building 31, 6th Floor,
Conference Room 6, 31 Center Drive, Bethesda, MD 20892.
Contact Person: Lyric Jorgenson, Health Sciences Policy Analyst
Office of Science Policy, Office of the Director, NIH, National
Institutes of Health, Building 1, Room 218, MSC 0166, 9000 Rockville
Pike, Bethesda, MD 20892, [email protected], (301) 496-6837.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
The meeting will also be webcast. The draft meeting agenda and
other information about the SMRB, including information about access
to the webcast, will be available at http://smrb.od.nih.gov.
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus. All visitor vehicles,
including taxis, hotel, and airport shuttles will be inspected
before being allowed on campus. Visitors will be asked to show one
form of identification (for example, a government-issued photo ID,
driver's license, or passport) and to state the purpose of their
visit.
(Catalogue of Federal Domestic Assistance Program Nos. 93.14,
Intramural Research Training Award; 93.22, Clinical Research Loan
Repayment Program for Individuals from Disadvantaged Backgrounds;
93.232, Loan Repayment Program for Research Generally; 93.39,
Academic Research Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan Repayment Program; 93.187,
Undergraduate Scholarship Program for Individuals from Disadvantaged
Backgrounds, National Institutes of Health, HHS)
Dated: August 16, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010-20675 Filed 8-19-10; 8:45 am]
BILLING CODE 4140-01-P